Lack of association of HLA-B*51 with a severe disease course in Behçet's disease

Rheumatology

Volumn 40, Issue 6, 2001, Pages 668-672

  Gul A ^a   Uyar, F A ^a   Inanc, M ^a   Ocal L ^a   Tugal Tutkun, I ^a   Aral, O ^a   Konice M ^a   Saruhan Direskeneli, G ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Beh et's disease; Disease severity; HLA B51; Homozygosity; Uveitis

Indexed keywords

HLA B ANTIGEN; HLA B51 ANTIGEN; UNCLASSIFIED DRUG;

ACNE; ADULT; AGED; ALLELE; ARTICLE; BEHCET DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; ERYTHEMA NODOSUM; EYE DISEASE; FEMALE; FOLLICULITIS; FOLLOW UP; GENE AMPLIFICATION; GENE SEQUENCE; GENETICS; GENITAL ULCER; HEALTH CENTER; HOMOZYGOSITY; HUMAN; HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; OLIGONUCLEOTIDE PROBE; OUTPATIENT DEPARTMENT; PATIENT REFERRAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEX DIFFERENCE; SKIN DEFECT; SKIN TEST; STATISTICAL ANALYSIS;

ADULT; AGED; BEHCET SYNDROME; FEMALE; HLA-B ANTIGENS; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 0034946604     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Behçet's syndrome
2. Recent advances in T-cell immunoregulation and the microbial causes of Behçet's disease
3. Etiopathology of Behçet's disease: Imunological aspects
4. Close association of HLA-Bw51 with Behçet's disease
5. Association of HLA-B51 and lack of association of class II alleles with Behçet's disease
6. Behçet's disease: Lack of correlation of clinical manifestations with HLA antigens
7. HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behçet's syndrome
8. Serological and molecular HLA typing in Italian Behçet's patients: Significant association to B51-DR5-DQw3 haplotype
9. An immunogenetic basis for the tissue involvement in Behçet's syndrome
10. Primary association of HLA-B51 with Behcet's disease in Ireland
11. Pathogenic gene responsible for the predisposition to Behçet's disease
12. The critical region for Behçet's disease in the human major histocompatibility complex is reduced to a 46-kb segment centromeric of HLA-B, by association analysis using refined microsatellite mapping
13. The prevalence of Behçet's syndrome in a rural area in northern Turkey
14. The association of HLA-B5 antigen with specific manifestations of Behçet's disease
15. HLA-B51 negative monozygotic twins discordant for Behçet's disease
16. The association between HLA-B5 and ocular involvement in Behçet's disease in southern Turkey
17. Prognostic factors of vision in patients with Behçet's disease
18. HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behçet's disease
19. Criteria for diagnosis of Behçet's disease
20. Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome
21. HLA class I DNA typing using sequence specific oligonucleotide probes (SSOP)
22. Locus-specific amplification of HLA class I genes from genomic DNA: Locus-specific sequences in the first and third introns of HLA-A, -B and -C alleles
23. Risk factors for vital organ involvement in Behçet's disease
24. Genetic anticipation in Behçet's disease
25. Childhood Behçet's disease: Clinical features and comparison with adult-onset disease
26. Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: A clue to major histocompatibility complex association with autoimmune disease
27. HLA-B27-derived peptides as autoantigens for T lymphocytes in ankylosing spondylitis
28. Anti-MHC autoimmunity in Behçet's disease: T cell responses to an HLA-B-derived peptide cross-reactive with retinal-S antigen in patients with uveitis
29. Close association of HLA-B51 and B52 in Israeli patients with Behçet's syndrome
30. Immunogenetic differences between patients with familial and non-familial rheumatoid arthritis